相关实验视频
Updated: Jul 25, 2025

05:22
Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
1.4K
中央血清性胆色素变异的表现和结果,有或没有帕奇科罗伊德
Sampurna Bhattacharyya1, Kumar Saurabh2, Sudipta Das2
1Aditya Birla Sankara Nethralaya, 147, Mukundapur, E. M. Bypass, Kolkata, 700 099, West Bengal, India.
Eye (London, England)
|June 27, 2023
概括
中央血清性胆色素变异症 (CSC) 与帕奇科罗伊德显示出更高的复发率和更糟糕的视觉结果. 患有帕奇科罗伊德CSC的患者比没有帕奇科罗伊德的患者体验到更少的自发解脱和更频繁的复发.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 冠状腺疾病 冠状腺疾病
背景情况:
- 中央血清性胆色素变异症 (CSC) 是一种影响视力的疾病.
- 双眼膜是眼睛的双眼膜层的加厚.
- 在CSC和 pachychoroid之间的关系需要进一步的研究.
研究的目的:
- 为了比较临床特征和CSC的结果在眼睛和没有 pachychoroid.
- 为了确定两组之间疾病进展和视力敏度的差异.
主要方法:
- 追溯的,纵向的,以记录为基础的研究,对250只眼睛进行了CSC.
- 用光谱域光学连贯性断层扫描技术,根据胸膜厚度和胸膜容器分类眼睛,分为双眼和非双眼组.
- 年龄,初始和最终最佳校正视敏度 (BCVA),自发解决率和复发率的比较.
主要成果:
- 群体之间的初始BCVA没有显著差异.
- 最终的BCVA在帕奇科罗伊德组 (0.37) 与非帕奇科罗伊德组 (0.21) 相比显著差.
- 自发解脱率较低 (28.8%),复发率较高 (31.2%) 在精神病组与非精神病组相比 (分别为48%和10.4%).
结论:
- 眼睛有CSC和大胆眼睛表现出更高的复发率和更少的自发分辨率.
- 帕奇科罗伊德与CSC患者的最终视力敏度较差有关.
- 建议通过更大规模的前性研究进一步验证.
更多相关视频
相关概念视频
Open Angle Glaucoma: Treatment
481
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
481
Angle Closure Glaucoma: Treatment
577
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
577

